These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2087060)

  • 1. [Type III hyperlipoproteinemia in idiopathic hemochromatosis].
    Feussner G; Ziegler R
    Klin Wochenschr; 1990; 68 Suppl 22():100-1. PubMed ID: 2087060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.
    Feussner G; Ziegler R
    Hum Genet; 1991 Jan; 86(3):326-8. PubMed ID: 1997392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipids and lipoproteins during therapy in a patient with familial type III hyperlipoproteinemia].
    Tozuka M; Hidaka H; Kanai M; Horigome R; Takase Y
    Rinsho Byori; 1983 Dec; 31(12):1317-24. PubMed ID: 6676485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute pancreatitis in type III hyperlipoproteinemia].
    Feussner G
    Internist (Berl); 1987 Jun; 28(6):393-5. PubMed ID: 3301725
    [No Abstract]   [Full Text] [Related]  

  • 5. [Idiopathic hemochromatosis. Review of the literature and study of 17 patients].
    Suárez J; Aliaga L; Sirvent L; Nunes R; Beloqui O; Prieto J
    Rev Med Univ Navarra; 1987; 31(1):15-21. PubMed ID: 3616359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Idiopathic hemochromatosis].
    Marin MG
    Minerva Med; 1985 Mar; 76(13):627-34. PubMed ID: 2986052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate intolerance in idiopathic haemochromatosis and cirrhosis of the liver.
    Stocks AE; Powell LW
    Q J Med; 1973 Oct; 42(168):733-49. PubMed ID: 4802417
    [No Abstract]   [Full Text] [Related]  

  • 8. [The characteristics of the clinical course of hereditary hemochromatosis].
    Valenkevich LN; Iakhontova OI
    Vrach Delo; 1991 May; (5):65-7. PubMed ID: 1866921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of precirrhotic hemochromatosis.
    Gushurst TP; Triest WE
    W V Med J; 1990 Mar; 86(3):91-5. PubMed ID: 2156380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type III hyperlipoproteinemia. A review and clinical and biochemical findings in 11 patients].
    Faergeman O; Meinertz H
    Ugeskr Laeger; 1980 Mar; 142(13):816-9. PubMed ID: 7368367
    [No Abstract]   [Full Text] [Related]  

  • 11. New diagnostic and therapeutic possibilities in manifest idiopathic hemochromatosis.
    Volkholz HJ; Sailer D; Rödl W
    Hepatogastroenterology; 1984 Dec; 31(6):289-94. PubMed ID: 6519641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinic and therapy of idiopathic hemochromatosis. Report of 51 cases (author's transl)].
    Fischer R
    Leber Magen Darm; 1976 Dec; 6(6):316-29. PubMed ID: 138778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of therapeutic plasmapheresis in the combined therapy of a female patient with idiopathic hemochromatosis].
    Krivosheev AB; Slinchenko II; Krivosheeva IA; Khromov EB
    Anesteziol Reanimatol; 1998; (4):50-2. PubMed ID: 9770821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic hemochromatosis.
    Kinney TB; Deluca SA
    Am Fam Physician; 1991 Sep; 44(3):873-5. PubMed ID: 1877429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
    Canzler H; Bojanovski D
    Artery; 1980; 8(2):171-8. PubMed ID: 7458684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic hemochromatosis in a young man presenting with palpitations.
    Vargas CA; Méndez HM; Rubio CE; Torres EA
    Bol Asoc Med P R; 1991 Jan; 83(1):19-21. PubMed ID: 2039574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypogonadal-induced anemia in genetic hemochromatosis: implications for phlebotomy therapy.
    Sigal SH; Fleischner GM; Weiner FR
    Am J Gastroenterol; 1995 Jan; 90(1):152-3. PubMed ID: 7801923
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary hemochromatosis: easily missed cause of cirrhosis, diabetes and heart failure.
    Giorgio AJ
    Geriatrics; 1973 Apr; 28(4):131-4. PubMed ID: 4700066
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative effects of bezafibrate and micronised fenofibrate in patients with type III hyperlipoproteinemia.
    Feussner G; Kurth B; Lohrmann J
    Eur J Med Res; 1997 Apr; 2(4):165-8. PubMed ID: 9110923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.